CUG-303

N/A

Report date: 2026/03/19 16:58:33

Base Information

Drug NameCUG-303

Drug Alias Nameanti-CD3 bispecific T-cell engager (Cugene)CUG-303

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionT cell surface glycoprotein CD3 modulators

TargetsT cell surface glycoprotein CD3

Therapy Area/IndicationsLeukemiaNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCugene Inc

China Registration ClassN/A

Develop Information

Active CompaniesCugene Inc

Inactive CompaniesN/A

Active IndicationsLeukemia

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A